A study by Xiao et al. has noted that upregulation of CCL20 in EBV-infected Hodgkin's lymphoma tumor microenvironment promotes the infiltration of Tregs, which in turn suppresses immune responses against EBV-infected tumors[49]. The gene discussed is CCL20; the disease is neoplasm.